Bret Jensen photo

STOCKS, TECHNOLOGY

Bret Jensen

Contributor,

Seeking Alpha's MarketPlace

  • Contributor for Seeking Alpha's Marketplace
  • 30 Years Industry Experience
  • BS in Finance from Arizona State with Minor in Accounting

About Bret

Bret Jensen has more than three decades of investing experience. He currently manages three investment services available via Seeking Alpha's MarketPlace and has been a paid contributor at Real Money Pro since 2010. Mr. Jensen has almost two decades of technology management experience as well as several years running a small hedge fund. He is primarily focused on the small-cap and biotech sectors in the market. Mr. Jensen has a BS in finance from Arizona State with a minor in accounting.

Bret's Videos

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

Bret Jensen has been monitoring the small and mid-cap biotech players as he expects to see M&A pick up in the next year.
Bret Jensen states that the election will not have a big impact on the biotech sector unless there is a clean sweep in the house.
Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene, and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.